Foot-and-Mouth Disease Virus Lacking the Leader Protein and Containing Two Negative DIVA Markers (FMDV LL3B3D A 24 ) Is Highly Attenuated in Pigs

Inactivated whole-virus vaccines are widely used for the control of foot-and-mouth disease (FMD). Their production requires the growth of large quantities of virulent FMD virus in biocontainment facilities, which is expensive and carries the risk of an inadvertent release of virus. Attenuated recomb...

Full description

Saved in:
Bibliographic Details
Published inPathogens (Basel) Vol. 9; no. 2; p. 129
Main Authors Eschbaumer, Michael, Dill, Veronika, Carlson, Jolene C, Arzt, Jonathan, Stenfeldt, Carolina, Krug, Peter W, Hardham, John M, Stegner, Jacob E, Rodriguez, Luis L, Rieder, Elizabeth
Format Journal Article
LanguageEnglish
Published Switzerland MDPI 17.02.2020
MDPI AG
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Inactivated whole-virus vaccines are widely used for the control of foot-and-mouth disease (FMD). Their production requires the growth of large quantities of virulent FMD virus in biocontainment facilities, which is expensive and carries the risk of an inadvertent release of virus. Attenuated recombinant viruses lacking the leader protease coding region have been proposed as a safer alternative for the production of inactivated FMD vaccines (Uddowla et al., 2012, 86:11675-85). In addition to the leader deletion, the marker vaccine virus FMDV LL3B 3D A encodes amino acid substitutions in the viral proteins 3B and 3D that allow the differentiation of infected from vaccinated animals and has been previously shown to be effective in cattle and pigs. In the present study, two groups of six pigs each were inoculated with live FMDV LL3B 3D A virus either intradermally into the heel bulb (IDHB) or by intra-oropharyngeal (IOP) deposition. The animals were observed for 3 or 5 days after inoculation, respectively. Serum, oral and nasal swabs were collected daily and a thorough postmortem examination with tissue collection was performed at the end of the experiment. None of the animals had any signs of disease or virus shedding. Virus was reisolated from only one serum sample (IDHB group, sample taken on day 1) and one piece of heel bulb skin from the inoculation site of another animal (IDHB group, necropsy on day 3), confirming that FMDV LL3B 3D A is highly attenuated in pigs.
AbstractList Inactivated whole-virus vaccines are widely used for the control of foot-and-mouth disease (FMD). Their production requires the growth of large quantities of virulent FMD virus in biocontainment facilities, which is expensive and carries the risk of an inadvertent release of virus. Attenuated recombinant viruses lacking the leader protease coding region have been proposed as a safer alternative for the production of inactivated FMD vaccines (Uddowla et al., 2012, J Virol 86:11675-85). In addition to the leader deletion, the marker vaccine virus FMDV LL3B PVKV 3D YR A 24 encodes amino acid substitutions in the viral proteins 3B and 3D that allow the differentiation of infected from vaccinated animals and has been previously shown to be effective in cattle and pigs. In the present study, two groups of six pigs each were inoculated with live FMDV LL3B PVKV 3D YR A 24 virus either intradermally into the heel bulb (IDHB) or by intra-oropharyngeal (IOP) deposition. The animals were observed for 3 or 5 days after inoculation, respectively. Serum, oral and nasal swabs were collected daily and a thorough postmortem examination with tissue collection was performed at the end of the experiment. None of the animals had any signs of disease or virus shedding. Virus was reisolated from only one serum sample (IDHB group, sample taken on day 1) and one piece of heel bulb skin from the inoculation site of another animal (IDHB group, necropsy on day 3), confirming that FMDV LL3B PVKV 3D YR A 24 is highly attenuated in pigs.
Inactivated whole-virus vaccines are widely used for the control of foot-and-mouth disease (FMD). Their production requires the growth of large quantities of virulent FMD virus in biocontainment facilities, which is expensive and carries the risk of an inadvertent release of virus. Attenuated recombinant viruses lacking the leader protease coding region have been proposed as a safer alternative for the production of inactivated FMD vaccines (Uddowla et al., 2012, J Virol 86:11675-85). In addition to the leader deletion, the marker vaccine virus FMDV LL3BPVKV3DYR A24 encodes amino acid substitutions in the viral proteins 3B and 3D that allow the differentiation of infected from vaccinated animals and has been previously shown to be effective in cattle and pigs. In the present study, two groups of six pigs each were inoculated with live FMDV LL3BPVKV3DYR A24 virus either intradermally into the heel bulb (IDHB) or by intra-oropharyngeal (IOP) deposition. The animals were observed for 3 or 5 days after inoculation, respectively. Serum, oral and nasal swabs were collected daily and a thorough postmortem examination with tissue collection was performed at the end of the experiment. None of the animals had any signs of disease or virus shedding. Virus was reisolated from only one serum sample (IDHB group, sample taken on day 1) and one piece of heel bulb skin from the inoculation site of another animal (IDHB group, necropsy on day 3), confirming that FMDV LL3BPVKV3DYR A24 is highly attenuated in pigs.
Inactivated whole-virus vaccines are widely used for the control of foot-and-mouth disease (FMD). Their production requires the growth of large quantities of virulent FMD virus in biocontainment facilities, which is expensive and carries the risk of an inadvertent release of virus. Attenuated recombinant viruses lacking the leader protease coding region have been proposed as a safer alternative for the production of inactivated FMD vaccines (Uddowla et al., 2012, 86:11675-85). In addition to the leader deletion, the marker vaccine virus FMDV LL3B 3D A encodes amino acid substitutions in the viral proteins 3B and 3D that allow the differentiation of infected from vaccinated animals and has been previously shown to be effective in cattle and pigs. In the present study, two groups of six pigs each were inoculated with live FMDV LL3B 3D A virus either intradermally into the heel bulb (IDHB) or by intra-oropharyngeal (IOP) deposition. The animals were observed for 3 or 5 days after inoculation, respectively. Serum, oral and nasal swabs were collected daily and a thorough postmortem examination with tissue collection was performed at the end of the experiment. None of the animals had any signs of disease or virus shedding. Virus was reisolated from only one serum sample (IDHB group, sample taken on day 1) and one piece of heel bulb skin from the inoculation site of another animal (IDHB group, necropsy on day 3), confirming that FMDV LL3B 3D A is highly attenuated in pigs.
Author Eschbaumer, Michael
Stenfeldt, Carolina
Krug, Peter W
Dill, Veronika
Arzt, Jonathan
Rodriguez, Luis L
Rieder, Elizabeth
Carlson, Jolene C
Hardham, John M
Stegner, Jacob E
AuthorAffiliation 2 Plum Island Animal Disease Center, USDA/ARS, Orient, NY 11957, USA; jonathan.arzt@usda.gov (J.A.); carolina.stenfeldt@usda.gov (C.S.); peter.krug@nih.gov (P.W.K.); luis.rodriguez@usda.gov (L.L.R.); elizabeth.rieder@usda.gov (E.R.)
1 Institute of Diagnostic Virology, Friedrich-Loeffler-Institut, Greifswald - Insel Riems 17493, Germany; veronika.dill@fli.de (V.D.); jolene.carlson@fli.de (J.C.C.)
4 Zoetis Inc., Kalamazoo, MI 49007, USA; john.m.hardham@zoetis.com (J.M.H.); c726087@gmail.com (J.E.S.)
3 Department of Diagnostic Medicine/Pathobiology, Kansas State University, Manhattan, KS 66506, USA
AuthorAffiliation_xml – name: 4 Zoetis Inc., Kalamazoo, MI 49007, USA; john.m.hardham@zoetis.com (J.M.H.); c726087@gmail.com (J.E.S.)
– name: 1 Institute of Diagnostic Virology, Friedrich-Loeffler-Institut, Greifswald - Insel Riems 17493, Germany; veronika.dill@fli.de (V.D.); jolene.carlson@fli.de (J.C.C.)
– name: 3 Department of Diagnostic Medicine/Pathobiology, Kansas State University, Manhattan, KS 66506, USA
– name: 2 Plum Island Animal Disease Center, USDA/ARS, Orient, NY 11957, USA; jonathan.arzt@usda.gov (J.A.); carolina.stenfeldt@usda.gov (C.S.); peter.krug@nih.gov (P.W.K.); luis.rodriguez@usda.gov (L.L.R.); elizabeth.rieder@usda.gov (E.R.)
Author_xml – sequence: 1
  givenname: Michael
  surname: Eschbaumer
  fullname: Eschbaumer, Michael
  organization: Institute of Diagnostic Virology, Friedrich-Loeffler-Institut, Greifswald - Insel Riems 17493, Germany
– sequence: 2
  givenname: Veronika
  surname: Dill
  fullname: Dill, Veronika
  organization: Institute of Diagnostic Virology, Friedrich-Loeffler-Institut, Greifswald - Insel Riems 17493, Germany
– sequence: 3
  givenname: Jolene C
  surname: Carlson
  fullname: Carlson, Jolene C
  organization: Institute of Diagnostic Virology, Friedrich-Loeffler-Institut, Greifswald - Insel Riems 17493, Germany
– sequence: 4
  givenname: Jonathan
  surname: Arzt
  fullname: Arzt, Jonathan
  organization: Plum Island Animal Disease Center, USDA/ARS, Orient, NY 11957, USA
– sequence: 5
  givenname: Carolina
  surname: Stenfeldt
  fullname: Stenfeldt, Carolina
  organization: Department of Diagnostic Medicine/Pathobiology, Kansas State University, Manhattan, KS 66506, USA
– sequence: 6
  givenname: Peter W
  surname: Krug
  fullname: Krug, Peter W
  organization: Plum Island Animal Disease Center, USDA/ARS, Orient, NY 11957, USA
– sequence: 7
  givenname: John M
  surname: Hardham
  fullname: Hardham, John M
  organization: Zoetis Inc., Kalamazoo, MI 49007, USA
– sequence: 8
  givenname: Jacob E
  surname: Stegner
  fullname: Stegner, Jacob E
  organization: Zoetis Inc., Kalamazoo, MI 49007, USA
– sequence: 9
  givenname: Luis L
  surname: Rodriguez
  fullname: Rodriguez, Luis L
  organization: Plum Island Animal Disease Center, USDA/ARS, Orient, NY 11957, USA
– sequence: 10
  givenname: Elizabeth
  surname: Rieder
  fullname: Rieder, Elizabeth
  organization: Plum Island Animal Disease Center, USDA/ARS, Orient, NY 11957, USA
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32079312$$D View this record in MEDLINE/PubMed
BookMark eNpdksFv0zAUxiM0xMbYnRPycRwCjp069gWptJRVSmGH0av1kryk3lK72M7Q_oz9x0vpmDZ8sf3e9_38LH1vkyPrLCbJ-4x-4lzRzzuIG9ehDYoymjH1KjlhtBAplVlx9Ox8nJyFcE3HJen-_iY55mNT8YydJPcL52IKtklXbogbMjcBISBZGz8EUkJ9Y2xH4gZJidCgJ5feRTSWjBYyczaCsXvF1R9HfmAH0dwimS_XU7ICf4M-kPPFar4mZcm_8jmZEpaTj2QZyIXpNv0dmcaIdoCIDRmhl6YL75LXLfQBzx730-TX4tvV7CItf35fzqZlWueCxbQVIFABb7KGF1CzStYgqhplxiaqoFy0fP_jtlFF08pW1kxVClEIoAiFYvw0WR64jYNrvfNmC_5OOzD6b8H5ToOPpu5R8yavFEfBJIccqJRK5JPJpJpkkLO2kiPry4G1G6otNjXa6KF_AX3ZsWajO3eri0xIxvgIOH8EePd7wBD11oQa-x4suiFoxlXOcqaoGKX0IK29C8Fj-_RMRvU-GPr_YIyWD8_HezL8iwF_AMQGtmY
CitedBy_id crossref_primary_10_3389_fvets_2020_00465
crossref_primary_10_3389_fvets_2020_554305
crossref_primary_10_3390_vaccines11020450
crossref_primary_10_3389_fmicb_2020_610286
Cites_doi 10.1177/1040638719870859
10.1016/j.molimm.2011.09.009
10.1111/j.1865-1682.2011.01236.x
10.1016/S0264-410X(98)00029-2
10.1016/j.bbrc.2010.07.044
10.1006/viro.1996.8309
10.1128/JVI.01467-07
10.1016/j.vaccine.2009.08.039
10.1016/j.rvsc.2014.01.009
10.1371/journal.ppat.1000050
10.1128/JVI.00081-17
10.1586/erv.11.4
10.1371/journal.pone.0106859
10.1128/CMR.17.2.465-493.2004
10.1016/S0168-1702(02)00261-7
10.4142/jvs.2010.11.2.133
10.1186/1297-9716-44-116
10.1006/viro.1993.1267
10.1128/JCM.03370-12
10.1016/j.jviromet.2017.04.007
10.1128/JVI.01254-12
ContentType Journal Article
Copyright 2020 by the authors. 2020
Copyright_xml – notice: 2020 by the authors. 2020
DBID NPM
AAYXX
CITATION
7X8
5PM
DOA
DOI 10.3390/pathogens9020129
DatabaseName PubMed
CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle PubMed
CrossRef
MEDLINE - Academic
DatabaseTitleList
CrossRef

PubMed
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 2076-0817
ExternalDocumentID oai_doaj_org_article_3d4b93e6283a4a088964555b51a42fb8
10_3390_pathogens9020129
32079312
Genre Journal Article
GrantInformation_xml – fundername: Agricultural Research Service
  grantid: 58-8064-7-007-F
GroupedDBID 53G
5VS
8FE
8FH
AADQD
AAHBH
ADBBV
AFKRA
AFZYC
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BBNVY
BCNDV
BENPR
BHPHI
CCPQU
DIK
GROUPED_DOAJ
HCIFZ
HYE
IHR
KQ8
LK8
M48
M7P
MODMG
M~E
NPM
OK1
PGMZT
PIMPY
PROAC
RIG
RPM
AAYXX
CITATION
7X8
5PM
ID FETCH-LOGICAL-c462t-f6a6e9a3d1d37ac2b8ca6bce812597036f30008fd97df8f8c29b9ee66a0ea7923
IEDL.DBID RPM
ISSN 2076-0817
IngestDate Tue Oct 22 15:15:19 EDT 2024
Tue Sep 17 21:26:33 EDT 2024
Fri Aug 16 11:27:38 EDT 2024
Thu Sep 12 21:16:17 EDT 2024
Sat Sep 28 08:29:42 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords DIVA
foot-and-mouth disease virus
attenuated
marker virus
leaderless
Language English
License Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c462t-f6a6e9a3d1d37ac2b8ca6bce812597036f30008fd97df8f8c29b9ee66a0ea7923
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0002-7517-7893
0000-0002-1104-0695
0000-0002-2074-3886
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7168223/
PMID 32079312
PQID 2394242906
PQPubID 23479
ParticipantIDs doaj_primary_oai_doaj_org_article_3d4b93e6283a4a088964555b51a42fb8
pubmedcentral_primary_oai_pubmedcentral_nih_gov_7168223
proquest_miscellaneous_2394242906
crossref_primary_10_3390_pathogens9020129
pubmed_primary_32079312
PublicationCentury 2000
PublicationDate 20200217
PublicationDateYYYYMMDD 2020-02-17
PublicationDate_xml – month: 2
  year: 2020
  text: 20200217
  day: 17
PublicationDecade 2020
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
PublicationTitle Pathogens (Basel)
PublicationTitleAlternate Pathogens
PublicationYear 2020
Publisher MDPI
MDPI AG
Publisher_xml – name: MDPI
– name: MDPI AG
References Medina (ref_13) 1993; 194
Rodriguez (ref_3) 2009; 27
Mason (ref_8) 1997; 227
Doel (ref_2) 2003; 91
Uddowla (ref_9) 2012; 86
LaRocco (ref_21) 2013; 51
Belsham (ref_12) 2005; 288
Pacheco (ref_18) 2010; 11
ref_22
Chinsangaram (ref_7) 1998; 16
Grubman (ref_1) 2004; 17
ref_20
Stenfeldt (ref_19) 2014; 96
Wang (ref_16) 2011; 49
Rai (ref_10) 2017; 91
Dill (ref_23) 2019; 31
Jamal (ref_11) 2013; 44
Rodriguez (ref_4) 2011; 10
Grubman (ref_15) 2007; 81
Strohmaier (ref_5) 1990; 97
Arzt (ref_17) 2011; 58
Wang (ref_14) 2010; 399
Dill (ref_24) 2017; 246
ref_6
References_xml – volume: 31
  start-page: 778
  year: 2019
  ident: ref_23
  article-title: Reliable detection, sequencing, and transfection of foot-and-mouth disease virus RNA from badly preserved vesicular epithelium
  publication-title: J. Vet. Diagn Invest.
  doi: 10.1177/1040638719870859
  contributor:
    fullname: Dill
– volume: 49
  start-page: 407
  year: 2011
  ident: ref_16
  article-title: Foot-and-mouth disease virus (FMDV) leader proteinase negatively regulates the porcine interferon-lambda1 pathway
  publication-title: Mol. Immunol.
  doi: 10.1016/j.molimm.2011.09.009
  contributor:
    fullname: Wang
– volume: 58
  start-page: 305
  year: 2011
  ident: ref_17
  article-title: The pathogenesis of foot-and-mouth disease II: Viral pathways in swine, small ruminants, and wildlife; myotropism, chronic syndromes, and molecular virus-host interactions
  publication-title: Transbound. Emerg. Dis.
  doi: 10.1111/j.1865-1682.2011.01236.x
  contributor:
    fullname: Arzt
– volume: 16
  start-page: 1516
  year: 1998
  ident: ref_7
  article-title: Protection of swine by live and inactivated vaccines prepared from a leader proteinase-deficient serotype A12 foot-and-mouth disease virus
  publication-title: Vaccine
  doi: 10.1016/S0264-410X(98)00029-2
  contributor:
    fullname: Chinsangaram
– volume: 399
  start-page: 72
  year: 2010
  ident: ref_14
  article-title: Foot-and-mouth disease virus leader proteinase inhibits dsRNA-induced type I interferon transcription by decreasing interferon regulatory factor 3/7 in protein levels
  publication-title: Biochem. Biophys. Res. Commun.
  doi: 10.1016/j.bbrc.2010.07.044
  contributor:
    fullname: Wang
– volume: 227
  start-page: 96
  year: 1997
  ident: ref_8
  article-title: Evaluation of a live-attenuated foot-and-mouth disease virus as a vaccine candidate
  publication-title: Virology
  doi: 10.1006/viro.1996.8309
  contributor:
    fullname: Mason
– volume: 81
  start-page: 12803
  year: 2007
  ident: ref_15
  article-title: Degradation of nuclear factor kappa B during foot-and-mouth disease virus infection
  publication-title: J. Virol.
  doi: 10.1128/JVI.01467-07
  contributor:
    fullname: Grubman
– volume: 27
  start-page: D90
  year: 2009
  ident: ref_3
  article-title: Foot and mouth disease virus vaccines
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2009.08.039
  contributor:
    fullname: Rodriguez
– volume: 288
  start-page: 43
  year: 2005
  ident: ref_12
  article-title: Translation and replication of FMDV RNA
  publication-title: Curr. Top. Microbiol. Immunol.
  contributor:
    fullname: Belsham
– volume: 96
  start-page: 396
  year: 2014
  ident: ref_19
  article-title: Infection dynamics of foot-and-mouth disease virus in pigs using two novel simulated-natural inoculation methods
  publication-title: Res. Vet. Sci.
  doi: 10.1016/j.rvsc.2014.01.009
  contributor:
    fullname: Stenfeldt
– ident: ref_6
  doi: 10.1371/journal.ppat.1000050
– volume: 91
  start-page: e00081-17
  year: 2017
  ident: ref_10
  article-title: Attenuation of Foot-and-Mouth Disease Virus by Engineered Viral Polymerase Fidelity
  publication-title: J. Virol.
  doi: 10.1128/JVI.00081-17
  contributor:
    fullname: Rai
– volume: 10
  start-page: 377
  year: 2011
  ident: ref_4
  article-title: Development of vaccines toward the global control and eradication of foot-and-mouth disease
  publication-title: Expert Rev. Vaccines
  doi: 10.1586/erv.11.4
  contributor:
    fullname: Rodriguez
– ident: ref_20
  doi: 10.1371/journal.pone.0106859
– volume: 17
  start-page: 465
  year: 2004
  ident: ref_1
  article-title: Foot-and-mouth disease
  publication-title: Clin. Microbiol. Rev.
  doi: 10.1128/CMR.17.2.465-493.2004
  contributor:
    fullname: Grubman
– volume: 91
  start-page: 81
  year: 2003
  ident: ref_2
  article-title: FMD vaccines
  publication-title: Virus Res.
  doi: 10.1016/S0168-1702(02)00261-7
  contributor:
    fullname: Doel
– ident: ref_22
– volume: 97
  start-page: 210
  year: 1990
  ident: ref_5
  article-title: Conclusions from the outbreak of foot-and-mouth disease in the government district of Hannover in 1987/1988
  publication-title: Dtsch. Tierarztl. Wochenschr.
  contributor:
    fullname: Strohmaier
– volume: 11
  start-page: 133
  year: 2010
  ident: ref_18
  article-title: Evaluation of infectivity and transmission of different Asian foot-and-mouth disease viruses in swine
  publication-title: J. Vet. Sci.
  doi: 10.4142/jvs.2010.11.2.133
  contributor:
    fullname: Pacheco
– volume: 44
  start-page: 1
  year: 2013
  ident: ref_11
  article-title: Foot-and-mouth disease: Past, present and future
  publication-title: Vet. Res.
  doi: 10.1186/1297-9716-44-116
  contributor:
    fullname: Jamal
– volume: 194
  start-page: 355
  year: 1993
  ident: ref_13
  article-title: The two species of the foot-and-mouth disease virus leader protein, expressed individually, exhibit the same activities
  publication-title: Virology
  doi: 10.1006/viro.1993.1267
  contributor:
    fullname: Medina
– volume: 51
  start-page: 1714
  year: 2013
  ident: ref_21
  article-title: A continuous bovine kidney cell line constitutively expressing bovine alphavbeta6 integrin has increased susceptibility to foot-and-mouth disease virus
  publication-title: J. Clin. Microbiol.
  doi: 10.1128/JCM.03370-12
  contributor:
    fullname: LaRocco
– volume: 246
  start-page: 58
  year: 2017
  ident: ref_24
  article-title: Simple, quick and cost-efficient: A universal RT-PCR and sequencing strategy for genomic characterisation of foot-and-mouth disease viruses
  publication-title: J. Virol. Methods
  doi: 10.1016/j.jviromet.2017.04.007
  contributor:
    fullname: Dill
– volume: 86
  start-page: 11675
  year: 2012
  ident: ref_9
  article-title: A safe foot-and-mouth disease vaccine platform with two negative markers for differentiating infected from vaccinated animals
  publication-title: J. Virol.
  doi: 10.1128/JVI.01254-12
  contributor:
    fullname: Uddowla
SSID ssj0000800817
Score 2.1887224
Snippet Inactivated whole-virus vaccines are widely used for the control of foot-and-mouth disease (FMD). Their production requires the growth of large quantities of...
SourceID doaj
pubmedcentral
proquest
crossref
pubmed
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 129
SubjectTerms attenuated
Brief Report
diva
foot-and-mouth disease virus
leaderless
marker virus
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Na9wwEBUlUOil9LtO2zCFHpqD6VqSZem46XZJym7IIVlyM5IlJ1uKHWIvJb-if7kz1ibZDYVeevHBn2JmxLyxRu8x9slo7kVQKrXauVQa5VNXmxEetNfe8cLUtFF4fqwOz-T38_x8Q-qLesIiPXA03BfhpTP4NkyDVlpqylEyz3OXZ1by2sVtviOzUUz9WOMgnRVxXVJgXU_91Zct-qQzCJCyAVHe56GBrv9vGPNhq-RG7pk-Y0_XoBHGcbDP2aPQvGCPo4zkzUv2e9q2fWobn85JEA8mcdEFFsvrVQczW9HvcECkB1FQE06InGHZAD4CRE8VVSLg9FcLx-FioAKHydFiDLSTB_EhfJ7OJwuYzcSBmMCYy3046oBaRH7ewLhH2L1CyOoBX3myvOhesbPpt9Ovh-laaCGtpOJ9WiurgrHCZ14UtuJOV1a5KmDyx3oDc1wtyKS1N4Wvda0rbpwJ6GE7CpYICF-znaZtwlsGaHRe2UxZURHTn9HaukoXEqe5FlrmCdu_NXt5Ffk0SqxDyEXlQxcl7ID8cncfMWEPJzA-ynV8lP-Kj4R9vPVqiTOHlkNsE9pVV5IoPAIUM1IJexO9fPcpwYk4MOMJK7b8vzWW7SvN8nJg58YCFEGX2P0fg3_HnnCq70mApnjPdvrrVfiAIKh3e0O8_wHSXQSB
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Scholars Portal Journals: Open Access(OpenAccess)
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nb9NAEF1BEagXxDcuHxokDvRgFO-u17sHhFJC1KKk6qGJerN2vXYaVNk0TgT5FfxlZmynkConLj7Y3sSamfW85519w9h7o7kXuVKh1c6F0igfusL08KC99o4npqCNwuNTdTyR3y7ii7_bozsD1jupHfWTmiyuPv66Xn_GCf-JGCdSdiqdvqzQ3LVB7IP56y67xyXydCrk68D-9w4b6Shp1yp3DtxnDwQnxbiIb6WpRs1_FwS9XUn5T2oaPmIPO0wJ_TYIHrM7efmE3W-7TK6fst_DqlqGtvThmPrlwaBdk4HpfLGqYWQz-loOCASh7bcJZ6TdMC8BhwCpV7VNJOD8ZwWn-axRCofBybQPtNEH4SN8GI4HUxiNxJEYQJ_LQzipgSpIrtbQXyIqXyGi9YA_eTaf1c_YZPj1_Mtx2PVhCDOp-DIslFW5scJHXiQ2405nVrksR2yAdARTYCHIuoU3iS90oTNunMkxAGwvt6RP-JztlVWZv2SA9ueZjZQVGQkBGq2ty3Qi8S2ghZZxwA43Zk9_tHIbKdIU8lZ621sBOyK_3NxHQtnNiWoxS7t5lwovncFgRBRlpaWaLiXjOHZxZCUvnA7Yu41XU5xYtFpiy7xa1Sn1jEf8YnoqYC9aL9_81SZKApZs-X_rWbavlPPLRrwb-SliMnHw3yNfsX1OnJ-a0iSv2d5yscrfIDBaurdNvP8Bm4YO1A
  priority: 102
  providerName: Scholars Portal
Title Foot-and-Mouth Disease Virus Lacking the Leader Protein and Containing Two Negative DIVA Markers (FMDV LL3B3D A 24 ) Is Highly Attenuated in Pigs
URI https://www.ncbi.nlm.nih.gov/pubmed/32079312
https://search.proquest.com/docview/2394242906
https://pubmed.ncbi.nlm.nih.gov/PMC7168223
https://doaj.org/article/3d4b93e6283a4a088964555b51a42fb8
Volume 9
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bT9swFLaAaRMv066su1Rn0h7GQ2hjO4792FIqmNqqmqDiLfIlKZ0gQU0rxK_gL-84SRFFe9pLHpI4sfwd63zHPv4OIT-UpI6lQgRaGhNwJVxgMtXFi3TSGRqrzB8UHk_E6QX_dRld7pBocxamStq3ZnGUX98c5YurKrfy9sZ2Nnlinen4GDk--jXW2SW7aKBPQvQ_DQWSYVxvSTIM6X1q9VWBcJQKuRH6t33yilEvDBfSLW9Uifb_i2k-T5h84oGGb8jrhjpCr-7iW7KT5u_Iy7qY5P178jAsilWgcxeMfVk8GNRbLzBbLNcljLT1i-KAfA_qspow9RINixywCXiRqrpWBJzfFTBJ55UgOAzOZj3w53mQJcLP4Xgwg9GI9dkAepQfwlkJPlHk-h56KyTfaySuDvCT08W8_EAuhifnx6dBU24hsFzQVZAJLVKlmQsdi7WlRlotjE2RAmDUgZ4uY350M6dil8lMWqqMShFn3U21lyH8SPbyIk8_EcDxp1aHQjPr9f6UlNpYGXOc7JJJHrXI4WbYk9taVSPBaMSjlTxHq0X6HpfH97wednWjWM6TxioS5rhRaHNIljTXPnVL8CiKTBRqTjMjW-T7BtUE54_fFNF5WqzLxJeGR5qiuqJFDmqUH3-1sZIWibfw3-rL9hM02UqjuzHRz__d8gvZpz6097Vn4q9kb7Vcp9-Q_6xMm7zon0ymv9vV-gFex1y2qznwFxEnCUw
link.rule.ids 230,315,730,783,787,867,888,2109,2228,24330,27936,27937,33757,53804,53806
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3JbtswECXSFG1z6b646xTooTnIC0lR5NGJa9itbfjgGLkJXCTHbSIFtowi_Yn-coeSFcRBL-1FB0mUKMyj5g05fEPIJyWpY4kQgZbGBFwJF5hUtfEgnXSGRir1G4XHEzE44V9Pw9M9EtZ7YcqkfWuWzez8opktz8rcyssL26rzxFrT8TFyfPRrrHWH3MXx2uY3gvTvWxIkO1G1KMkwqPfJ1Wc5GmStkB2hhzsg9xn10nAduuOPStn-v3HN2ymTN3xQ_xGZ172vUk9-NDeFadpft4Qd__nzHpOHW1YK3eryE7KXZE_JvapO5dUz8ruf50WgMxeMfcU96FWrOjBfrjZrGGnr59sBqSRUFTth6tUflhlgE_D6V1UZCpj9zGGSLEqtcegN513wW4WQgMLn_rg3h9GIHbEedCk_hOEafA7K-RV0C-T1G-TEDvCR0-Vi_Zyc9L_MjgfBtpJDYLmgRZAKLRKlmes4FmlLjbRaGJsgu8CABp1oyrzZUqcil8pUWqqMShBCup1or3D4guxneZa8IoCGpVZ3hGbWSwkqKbWxMuL4H5FM8rBBDmt7xpeVYEeMgY6HQXwbBg1y5A1-fZ-X2i5P5KtFvLVIzBw3CuGMPExz7bPCBA_D0IQdzWlqZIN8rOES49D06y06S_LNOvZV55EBqbZokJcVfK5fVcOvQaIdYO30ZfcKwqWU_97C4_V_t_xAHgxm41E8Gk6-vSEH1M8g-BI30VuyX6w2yTukWYV5Xw6qP8p2J9Y
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3JbtswECXaFA1ySffGXadAD81BtkVKFHl04hpxaxs-JEbQi8BFctwmkmFLKNKf6C93KNmBbfSUiw4StRDzqHlDDt8Q8lkKalnCuaeE1l4gufV0Ktt4EFZYTSOZuo3CwxE_uwi-XYaXG6W-qqR9o2fN7Pqmmc2uqtzK-Y1prfPEWuPhKXJ89GusNbdp6yF5hGO2zTcC9Z8rIiT8qF6YZBjYuwTrqxyNspTIkNDLHZB9Rp08nE-3fFIl3f8_vrmbNrnhh3pPyI91D-r0k1_NstBN82dH3PFeXXxKDlfsFDp1k2fkQZI9J4_repW3L8jfXp4XnsqsN3SV96Bbr-7AZLYolzBQxs27A1JKqCt3wtipQMwywFvA6WDV5Sjg_HcOo2RaaY5Dtz_pgNsyhEQUvvSG3QkMBuyEdaFDg2PoL8HlolzfQqdAfl8iN7aAjxzPpsuX5KL39fz0zFtVdPBMwGnhpVzxRCpmfcsiZagWRnFtEmQZGNigM02ZM11qZWRTkQpDpZYJQkm1E-WUDl-RvSzPkiMCaFxqlM8VM05SUAqhtBFRgP8TwUQQNsjx2qbxvBbuiDHgcVCId6HQICfO6HftnOR2dSJfTOOVVWJmAy0R1sjHVKBcdhgPwjDUoa8CmmrRIJ_WkIlxiLp1F5UlebmMXfV5ZEKyzRvkdQ2hu1etIdgg0Ra4tr5l-wpCppIBX0Hkzb3v_Ej2x91ePOiPvr8lB9RNJLhKN9E7slcsyuQ9sq1Cf6jG1T8O9CpW
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Foot-and-Mouth+Disease+Virus+Lacking+the+Leader+Protein+and+Containing+Two+Negative+DIVA+Markers+%28FMDV+LL3B3D+A24%29+Is+Highly+Attenuated+in+Pigs&rft.jtitle=Pathogens+%28Basel%29&rft.au=Eschbaumer%2C+Michael&rft.au=Dill%2C+Veronika&rft.au=Carlson%2C+Jolene+C.&rft.au=Arzt%2C+Jonathan&rft.date=2020-02-17&rft.pub=MDPI&rft.eissn=2076-0817&rft.volume=9&rft.issue=2&rft_id=info:doi/10.3390%2Fpathogens9020129&rft_id=info%3Apmid%2F32079312&rft.externalDBID=PMC7168223
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2076-0817&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2076-0817&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2076-0817&client=summon